(1)
Blauvelt, A.; Paul, C.; van de Kerkhof, P.; Warren, R. B.; Gottlieb, A. B.; Langley, R. G.; Brock, F.; Arendt, C.; Boehnlein, M.; Lebwohl, M.; Reich, K. Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. J of Skin 2020, 4, s46.